Gastroenteritis: Clinical Trials

89 trials for Gastroenteritis, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

89 unknown. 89 Phase 2, 24 Phase 1, 21 Phase 3.

By phase and status

PhaseTrialsStatus
Phase 289Unknown 89
Phase 124Unknown 24
Phase 321Unknown 21

Follow Gastroenteritis: new trials by email Literature Review of Gastroenteritis trials Research Report on Gastroenteritis

Trials (filtered) newest first · largest first

All 89 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Beta-Hydroxybutyrate Feasibility Treating IBD
Feasibility of beta-hydroxybutyrate supplementation to reduce inflammation in patients with Crohn's - Crohn's Disease, Inflammatory Bowel Diseases
Phase 1 / Phase 2UnknownUniversity of Texas at Austin202024-08-282024-09-19
Phase 2 Study of CU104 in Moderate-Severe Ulcerative Colitis
CU104, Placebo - Ulcerative Colitis
Phase 2UnknownCuracle Co., Ltd.452024-06-012023-06-18
Unravelling Intestinal Fibrosis in Ulcerative Colitis
Fibroblast Activation Protein Inhibitor - Ulcerative Colitis (UC), Inflammatory Bowel Disease (IBD)
Phase 2 / Phase 3UnknownAcademisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA)102024-04-032024-09-19
Fluorescence Imaging of Adalimumab-680LT in Inflammatory Bowel Disease
Adalimumab-680LT, Control - Crohn Disease, Ulcerative Colitis
Phase 1 / Phase 2UnknownUniversity Medical Center Groningen212024-03-012024-03-12
FAPi-PET Imaging of in Vivo Fibrosis in Inflammatory Bowel Disease Patients
68Ga-FAPi-46 - IBD (Inflammatory Bowel Disease), Crohn Disease (CD)
Phase 2UnknownDalia Lartey202023-08-312024-09-19
Saffron and Ulcerative Colitis
Saffron 100, Saffron 50, Placebo - Ulcerative Colitis
Phase 2UnknownShiraz University of Medical Sciences602023-05-012022-05-11
Phase 2a Study to Evaluate IcBD-01 Enema in Active Ulcerative Colitis Patients
CBD, synthetic form, Placebo - Ulcerative Colitis
Phase 2UnknownCannaMore Biotechs452023-03-012024-04-09
Deep-sea Fish Oil for Prevention of Acute Radiation-induced Esophagitis
Deep-sea fish oil, Placebo - Radiation Toxicity, Esophagitis
Phase 2UnknownFirst Affiliated Hospital of Chengdu Medical College1202023-01-152024-05-01
A Study of Anaprazole Sodium Enteric-coated Tablets in the Treatment of Reflux Esophagitis
Anaprazole sodium 40 mg, Anaprazole sodium 60 mg, Rabeprazole sodium 20 mg - Reflux Esophagitis, Gastroesophageal Reflux
Phase 2UnknownXuanzhu Biopharmaceutical Co., Ltd.1562022-12-012022-11-03
Transversus Abdominis Plane Blocks With and Without Dexamethasone
Dexamethasone - Colorectal Disorders, Regional Anesthesia Morbidity
Phase 1 / Phase 2UnknownUniversity of Saskatchewan602022-09-012023-12-07
Combination of Curcumin and Berberine Therapy in the Treatment of Post Acute Diverticulitis (SUDD)
Curcumin-Berberine (coptis), Placebo - Diverticulitis
Phase 2UnknownDr. Adi Lahat402022-08-142023-12-08
Phase 2a Study to Evaluate Suppression of Radiotherapy-induced Mucositis by TK112690
TK-112690, Placebo - Mucositis
Phase 2UnknownTosk, Inc.242022-06-172023-08-14
Phase 2a Study to Evaluate Suppression of 5-Fluorouracil -Induced Mucositis by TK112690
TK-112690, Placebo - Mucositis
Phase 2UnknownTosk, Inc.242022-06-152023-08-14
Budesonide Multimatrix(MMX) Versus Prednisolone in Management of Mild to Moderate Ulcerative Colitis
Budesonide MMX, Prednisolone - Ulcerative Colitis Chronic
Phase 2 / Phase 3UnknownAssiut University1002022-06-012022-04-22
Exclusion Diet vs corticosteroIds in patientS With activE Crohn's Disease
Crohn's disease exclusion diet (CDED), Oral prednisolone - Crohn Disease
Phase 2 / Phase 3UnknownAssistance Publique - Hôpitaux de Paris802022-04-012022-03-17
Targeted Elimination Diet in EoE Patients Following Identification of Trigger Nutrients Using Confocal Laser Endomicroscopy
personalized exclusion diet based on CLE, empiric exclusion diet - Eosinophilic Esophagitis
Phase 1 / Phase 2UnknownUniversitaire Ziekenhuizen KU Leuven252022-02-162024-06-27
Seeded Cells on Matrix Plug Treating Crohn's Perianal Fistulas (STOMP-II)
Seton Placement, AVB-114 - Perianal Fistula, Crohn's Disease
Phase 2UnknownAvobis Bio, LLC602021-09-132024-08-01
GM-CSF, Fosfomycin and Metronidazole for Pouchitis in Ulcerative Colitis Patients After Restorative IPAA Surgery
GM-CSF, fosfomycin and metronidazole - Pouchitis
Phase 1 / Phase 2UnknownZealand University Hospital182021-09-062023-01-26
The Effect of Alpha Lipoic Acid on the Incidence and Severity of Radiotherapy-Induced Oral Mucositis in Head and Neck Cancer Patients
Alpha Lipoic Acid 600 MG Oral Tablets, Placebo tablets, radiation or concurrent chemoradiation - Radiation-Induced Mucositis
Phase 2 / Phase 3UnknownAin Shams University702021-09-012021-08-27
Efficacy and Safety of Three Doses of Florence Oral Suspension in Adults With Eosinophilic Esophagitis
Florence 30 μg/mL, Florence 60 μg/mL, Florence 90 μg/mL - Eosinophilic Esophagitis
Phase 2UnknownEMS1162021-04-192023-02-24

Showing 20 of 89. Sign in to see all of them.

Narrower conditions

Colitis, Ulcerative (33)  ·  Crohn Disease (23)  ·  Inflammatory Bowel Diseases (20)  ·  Mucositis (11)  ·  Enterocolitis, Necrotizing (7)  ·  Colorectal Neoplasms (4)  ·  Diverticular Diseases (4)  ·  Neoplasms (4)  ·  Stomatitis (4)  ·  Colitis (3)  ·  Eosinophilic Esophagitis (3)  ·  Esophagitis (3)  ·  Gastritis (3)  ·  Gastrointestinal Diseases (3)  ·  Head and Neck Neoplasms (3)

Broader conditions

Digestive System Diseases (87)  ·  Gastrointestinal Diseases (86)  ·  Intestinal Diseases (68)  ·  Colonic Diseases (39)  ·  Inflammatory Bowel Diseases (34)  ·  Colitis (31)  ·  Pathological Conditions, Signs and Symptoms (16)  ·  Neoplasms (11)  ·  Pathologic Processes (11)  ·  Mouth Diseases (10)  ·  Neoplasms by Site (10)  ·  Stomatognathic Diseases (10)  ·  Enterocolitis (8)  ·  Infections (8)

Interventions

Fecal Microbiota Transplantation (5)  ·  Saline Solution (4)  ·  Mesalamine (3)  ·  Metronidazole (3)  ·  Amoxicillin (2)  ·  Clarithromycin (2)  ·  Prednisolone (2)  ·  Rabeprazole (2)  ·  2-(1-carboxy-2-(3-(3,5-dichlorobenzyl)-3H-imidazol-4-yl)ethylamino)-4-methylpentanoic acid (1)  ·  4'-galactooligosaccharide (1)  ·  Appendectomy (1)  ·  Artesunate (1)  ·  Cell- and Tissue-Based Therapy (1)  ·  Coptis extract (1)  ·  Curcumin (1)

Sponsors

Shaare Zedek Medical Center (3)  ·  Assaf-Harofeh Medical Center (2)  ·  Assistance Publique - Hôpitaux de Paris (2)  ·  First Affiliated Hospital of Chengdu Medical College (2)  ·  McGill University Health Centre/Research Institute of the McGill University Health Centre (2)  ·  Sixth Affiliated Hospital, Sun Yat-sen University (2)  ·  Tosk, Inc. (2)  ·  University College Cork (2)  ·  University of Aarhus (2)  ·  Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA) (1)  ·  Acibadem University (1)  ·  Affiliated Hospital to Academy of Military Medical Sciences (1)  ·  Ain Shams University (1)  ·  Altheus Therapeutics, Inc. (1)  ·  Applied Molecular Transport (1)

Countries

China (12)  ·  Israel (10)  ·  United States (10)  ·  Netherlands (6)  ·  Canada (5)  ·  Denmark (4)  ·  France (4)  ·  India (4)  ·  Italy (4)  ·  Belgium (3)  ·  Germany (3)  ·  United Kingdom (3)  ·  Egypt (2)  ·  Iran (2)  ·  Ireland (2)

Top investigators

Cathy Hammerman, MD (3)  ·  Emile Youssef, MD, PhD (2)  ·  Mark Lowenberg, MD PhD (2)  ·  Adi Lahat-Zok, MD (1)  ·  Adila SA Elobeid, PhD (1)  ·  Amy D Klion, M.D. (1)  ·  Bilgi Baca, MD,Prof.Dr. (1)  ·  Bing Liu, M.D. (1)  ·  David N Ginther, MD (1)  ·  Dongfeng Chen, doctor (1)  ·  Dr. Ryan O Lakin, MD JD (1)  ·  Edmund LaGamma, MD (1)  ·  Einat Dekel, DVM (1)  ·  Fahimeh Anbari, resident (1)

Results publications

PMID 22818551, PMID 23292233, PMID 23648372, PMID 24566744, PMID 24796768, PMID 25104129, PMID 25451666, PMID 25927273, PMID 26340878, PMID 26363929, PMID 29906796, PMID 30046225, PMID 30366723, PMID 30755154, PMID 30972640, PMID 31272391, PMID 31448214, PMID 32282545, PMID 32790844, PMID 32955197, PMID 33006765, PMID 33064186, PMID 33188747, PMID 33571293, PMID 35283330, PMID 35962454, PMID 39109266, PMID 39281978, PMID 40120806, PMID 40890737, PMID 41879234, PMID 42728546

NIH funding

2023 (2), 2005 (1), 2008 (1), 2014 (1), 2015 (1), K08HD052885 (1)